• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Setmelanotide Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5753896

Setmelanotide is a selective agonist of melanocortin 4 receptor (MC4R)(human and rat MC4R with EC50s of 0.27nM and 0.28nM, respectively). More details

DISCONTINUED
Click here to view our similar product(s) OR click here to contact our technical support team for suitable replacement.
Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Product Name
Setmelanotide, Inhibitor
Full Product Name
Setmelanotide
Product Synonym Names
RM-493; BIM-22493; IRC-022493
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
1117.31
Solubility
H2O: 100mg/mL (89.50mM) Need ultrasonic
DMSO: 100mg/mL (89.50mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C49H68N18O9S2
SMILES
O=C(N[C@@H](CSSC[C@](C(N[C@@H]1C)=O)([H])NC([C@@H](NC(C)=O)CCCNC(N)=N)=O)C(N)=O)[C@@H](NC([C@@H](NC([C@@](NC([C@@H](NC1=O)CC2=CN=CN2)=O)([H])CC3=CC=CC=C3)=O)CCCNC(N)=N)=O)CC4=CNC5=CC=CC=C45
CAS Number
920014-72-8
Target & IC50
hMC1R: ic50 3.9nM (ki)
hMC3R: ic50 10nM
hMC4R: ic50 2.1nM
hMC5R: ic50 1600nM
rMC4R: ic50 2.7nM
hMC1R: ic50 5.8nM (EC50)
hMC3R: ic50 5.3nM
hMC4R: ic50 0.27nM
rMC4R: ic50 0.28
In Vitro
Inhibition of refeeding after an overnight fast by BIM-22493 is dependent on functional MC4R glucose homeostasis acutely improved by BIM-22493. BIM-22493(Lepob/Lepob mice) exhibits significantly improved glucose clearance when compared to controls. Chronic BIM-22493 treatment was associated with significantly lower levels of serum insulin, glucose and HOMA-IR values, suggesting an improvement in insulin sensitivity[1]. Treatment with setmelanotide results in transient decreases in food intake (35%), with persistent weight loss over 8 weeks of treatment, (13.5%) in a diet-induced obese nonhuman primate model[2].

Product References and Citations for Setmelanotide, inhibitor

Kumar KG, et al. Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice. Peptides. 2009 Oct;30(10):1892-900.
Kumar KG, et al. Analysis of the therapeutic functions of novel melanocortin receptor agonists in MC3R- and MC4R-deficient C57BL/6J mice. Peptides. 2009 Oct;30(10):1892-900.
Kievit P, et al. Chronic treatment,with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes. 2013 Feb;62(2):490-7.
Kievit P, et al. Chronic treatment,with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques. Diabetes. 2013 Feb;62(2):490-7.

Other Notes

Small volumes of Setmelanotide, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Setmelanotide purchase

MBS5753896 is an inhibitor targeting Setmelanotide.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000